SAN FRANCISCO, California, March 23 /PRNewswire/ -- Synosis Therapeutics has changed its company name to Synosia Therapeutics effective immediately.
The company’s new website address is www.synosia.com and all email addresses are now @synosia.com. The mailing address and phone numbers remain the same.
About Synosia Therapeutics
Synosia Therapeutics is a privately-owned, drug development company, focused on developing new treatments for disorders of the central nervous system. Its leadership team has over 180 years of combined experience in drug development. Synosia has offices in Basel, Switzerland, and is headquartered in South San Francisco, CA. For more information, visit www.synosia.com
Synosis Therapeutics
CONTACT: Contact Synosia Therapeutics: In Europe: Julie Walters at MediaSpeak, Tel: +44-(0)-1494-753 990, Mobile +44-(0)-775-3626967,julie.walters@mediaspeak.com. In US: Michele Parisi at Media Speak, Tel:+1-925-864-5028, michele.parisi@mediaspeak.com
